z-logo
Premium
P4‐031: PLATELET APP RATIO IN AD PATIENTS TREATED WITH DONEPEZIL
Author(s) -
Sarno Tamires Alves,
Giroud Joaquim Helena Passarelli,
Talib Leda Leme,
Hototian Sergio,
Gattaz Wagner,
Forlenza Orestes Vicente
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1545
Subject(s) - donepezil , medicine , platelet , dementia , alzheimer's disease , amyloid precursor protein , disease , oncology
amyloid-b 40 with GAPDH aggregates revealed the significant pyramidal cell death and inflammation in the field of CA3, concomitant with the mitochondrial dysfunction. Conclusions: These findings suggest that GAPDH aggregates might act as a seed for amyloid-b 40 amyloidogenesis and enhances the cell death both in vitro and in vivo, providing a novel insight to investigate mechanisms underlying formation of amyloidal deposits such as senile and dendritic plaques in Alzheimer disease.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here